Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MD.0000000000000652 http://scihub22266oqcxt.onion/10.1097/MD.0000000000000652 C4602687!4602687 !25906091     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25906091 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Medicine+(Baltimore) 2015 ; 94 (16 ): e652 Nephropedia Template TP {{tp|p=25906091 |t=2015. A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer |pdf=|usr=}}{{25906091 }} gab.com Text A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer JO: Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=25906091 #FOAvip The aim of this study was to compare the efficacy and safety of S-1-based therapy versus non-S-1-based therapy in advanced gastric cancer (AGC) patients.Eligible studies stratifying objective response rate (ORR), progression-free survival (PFS), overall survival (OS), and adverse events (AEs) in AGC patients were identified from Embase, Pubmed, Cochrane Library, and China National Knowledge Infrastructure databases. The STATA package (version 11.0) was used to pool the data from the eligible studies.Fifteen studies with 2973 AGC cases, of which 1497 (50.4%) received S-1-based therapy and 1476 (49.6%) received non-S-1-based therapy, were identified in the meta-analysis. AGC patients who had received S-1-based therapy had a higher median OS, median PFS, and ORR than those who had received 5-fluorouracil (FU)-based therapy (OS: hazard ratio [HR] 0.89, 95% confidence interval [CI] 0.80-0.98, P?=?0.015; PFS: HR 0.88, 95% CI 0.80-0.98, P?=?0.016; ORR: OR 1.25, 95% CI 1.08-1.45, P?=?0.003, respectively). S-1-based therapy had similar efficacy to capecitabine-based therapy in terms of median OS (HR 1.14, 95% CI 0.91-1.41, P?=?0.253), median PFS (HR 1.01, 95% CI 0.82-1.25, P?=?0.927), and ORR (OR 0.84, 95% CI 0.63-1.12, P?=?0.226). Subgroup analysis for grade 3 to 4 toxicity showed higher incidence of neutropenia (relative risk [RR]?=?0.827, P?=?0.006), nausea (RR?=?0.808, P?=?0.040), and lower diarrhea (RR?=?1.716, P?=?0.012) in 5-FU-based arm, and higher diarrhea (RR?=?0.386, P?=?0.007) in capecitabine-based arm.S-1-based chemotherapy is favorable to AGC patients with better clinical benefit than 5-FU-based chemotherapy and with equivalent antitumor compare with capecitabine-based therapy. Twit Text FOAVip A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer ????Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=25906091 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25906091 #FOAvip English Wikipedia <ref>{{Cite pmid|25906091 }}</ref> A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer #MMPMID25906091 Wu FL ; Lu DC ; Ying YP ; Huang JJ ; Zhou AM ; Jiang DK ; Chen MW ; Yang X ; Zhou J ; Huang HQ ; Zeng HY Medicine (Baltimore) 2015[Apr]; 94 (16 ): e652 PMID25906091 show ga The aim of this study was to compare the efficacy and safety of S-1-based therapy versus non-S-1-based therapy in advanced gastric cancer (AGC) patients.Eligible studies stratifying objective response rate (ORR), progression-free survival (PFS), overall survival (OS), and adverse events (AEs) in AGC patients were identified from Embase, Pubmed, Cochrane Library, and China National Knowledge Infrastructure databases. The STATA package (version 11.0) was used to pool the data from the eligible studies.Fifteen studies with 2973 AGC cases, of which 1497 (50.4%) received S-1-based therapy and 1476 (49.6%) received non-S-1-based therapy, were identified in the meta-analysis. AGC patients who had received S-1-based therapy had a higher median OS, median PFS, and ORR than those who had received 5-fluorouracil (FU)-based therapy (OS: hazard ratio [HR] 0.89, 95% confidence interval [CI] 0.80-0.98, P?=?0.015; PFS: HR 0.88, 95% CI 0.80-0.98, P?=?0.016; ORR: OR 1.25, 95% CI 1.08-1.45, P?=?0.003, respectively). S-1-based therapy had similar efficacy to capecitabine-based therapy in terms of median OS (HR 1.14, 95% CI 0.91-1.41, P?=?0.253), median PFS (HR 1.01, 95% CI 0.82-1.25, P?=?0.927), and ORR (OR 0.84, 95% CI 0.63-1.12, P?=?0.226). Subgroup analysis for grade 3 to 4 toxicity showed higher incidence of neutropenia (relative risk [RR]?=?0.827, P?=?0.006), nausea (RR?=?0.808, P?=?0.040), and lower diarrhea (RR?=?1.716, P?=?0.012) in 5-FU-based arm, and higher diarrhea (RR?=?0.386, P?=?0.007) in capecitabine-based arm.S-1-based chemotherapy is favorable to AGC patients with better clinical benefit than 5-FU-based chemotherapy and with equivalent antitumor compare with capecitabine-based therapy. |Capecitabine [MESH] |China [MESH] |Clinical Trials as Topic [MESH] |Deoxycytidine/adverse effects/*analogs & derivatives/therapeutic use [MESH] |Disease-Free Survival [MESH] |Drug Combinations [MESH] |Female [MESH] |Fluorouracil/adverse effects/*analogs & derivatives/*therapeutic use [MESH] |Humans [MESH] |Male [MESH] |Oxonic Acid/adverse effects/*therapeutic use [MESH] |Severity of Illness Index [MESH] |Stomach Neoplasms/*drug therapy/*mortality [MESH]A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival o(epmc).pdf DeepDyve Pubget Overpricing